HLIT Stock Recent News

Harmonic's Hybrid, AI-Powered and Live Sports Streaming Innovations are Key to Elevating Viewing Experiences, Boosting Monetization and Optimizing Costs SAN JOSE, Calif. , July 15, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will showcase a collection of breakthrough innovations at IBC2025, reinforcing its leadership in video streaming and broadcast delivery.

SAN JOSE, Calif. , July 14, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will release its second quarter 2025 financial results after the market close on Monday, July 28, 2025.

SAN JOSE, Calif. , July 8, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced a record-breaking demonstration at the recent CableLabs® Interop event, setting a new industry benchmark for DOCSIS® 4.0 performance.

Harmonic's cOS Platform Enables Mediacom to Offer Multigigabit and Symmetrical Services with High Reliability, Lower Operating Costs and a Clear Path to Fiber SAN JOSE, Calif. , June 23, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Mediacom Communications, the fifth-largest cable operator in the U.S., has chosen Harmonic's industry-leading cOS™ virtualized broadband platform to modernize its network.

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform, today announces remarkable clinical observations for a patient in Lantern's Phase 2 HARMONIC™ clinical trial. A 70-year-old never-smoker with advanced non-small cell lung cancer (NSCLC) has achieved a durable complete response in their target cancer lesions following treatment with LP-300 in combination with standard-o.

Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third quarter of 2025 THB335 demonstrated 85% serum tryptase reduction with an encouraging safety profile in an additional Phase 1 cohort evaluating 100mg dose with new drug product capsule formulation Company initiating a sale process of THB335 SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD) today announced that its stockholders overwhelmingly approved the previously proposed Plan of Liquidation and Dissolution (the “Plan of Dissolution”) at the Company's Annual Meeting of Stockholders held on June 5, 2025. In addition, The Company also announced the results of a recently completed additional cohort in its Phase 1 clinical trial of its oral wild-type KIT inhibitor development candidate, THB335, a

Harmonic's virtualized cOS platform is selected by Vectra to propel Poland's multigigabit broadband evolution.

Advanced Integration Enables Exceptional Broadband Experiences for Latency-Sensitive Interactive Applications SAN JOSE, Calif. , June 3, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced a collaboration to integrate CUJO AI® network intelligence software with Harmonic's market-leading cOS™ virtualized broadband platform.

Harmonic's cOS Broadband Platform Enables World's First PTP-less Deployment to Fuel Vectra's Network Transformation and Enable Wholesale Fiber and DOCSIS Offerings SAN JOSE, Calif. , June 2, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Vectra, one of the largest internet providers in Poland, has selected Harmonic's industry-leading cOS™ virtualized broadband platform to accelerate its multigigabit broadband service expansion, enable selective migration to deep fiber infrastructure and power its new wholesale fiber and DOCSIS offerings.

HLIT launches SeaStar Optical Node to deliver high-speed broadband connectivity without costly infrastructure upgrades.